| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.93B | 3.59B | 3.62B | 3.55B | 2.95B |
| Gross Profit | 1.59B | 1.71B | 1.64B | 1.55B | 1.38B |
| EBITDA | 860.00M | 870.00M | -1.11B | 832.00M | 794.00M |
| Net Income | 295.00M | 190.00M | -1.84B | 333.00M | 551.00M |
Balance Sheet | |||||
| Total Assets | 8.80B | 8.59B | 9.12B | 11.49B | 4.54B |
| Cash, Cash Equivalents and Short-Term Investments | 675.00M | 714.00M | 875.00M | 910.00M | 1.04B |
| Total Debt | 4.69B | 4.78B | 5.02B | 5.17B | 1.03B |
| Total Liabilities | 6.08B | 6.27B | 6.65B | 7.01B | 1.65B |
| Stockholders Equity | 2.72B | 2.32B | 2.47B | 4.48B | 2.89B |
Cash Flow | |||||
| Free Cash Flow | 497.00M | 410.00M | 232.00M | 365.00M | 552.80M |
| Operating Cash Flow | 645.00M | 528.00M | 319.00M | 529.00M | 639.50M |
| Investing Cash Flow | -145.00M | -117.00M | -84.00M | -4.55B | -204.60M |
| Financing Cash Flow | -562.00M | -549.00M | -259.00M | 3.97B | -65.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $5.71B | 13.43 | 35.39% | 0.26% | 1.76% | 4.10% | |
71 Outperform | $8.81B | 46.06 | 7.61% | 0.89% | 10.23% | 25.53% | |
71 Outperform | $7.53B | 42.40 | 9.74% | ― | 7.40% | 13.79% | |
69 Neutral | $15.64B | 36.46 | 11.74% | 0.54% | 8.13% | 780.20% | |
69 Neutral | $4.22B | 13.96 | 19.38% | ― | 0.14% | 14.12% | |
68 Neutral | $5.15B | 155.81 | -0.92% | 1.43% | -8.07% | 63.50% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On February 4, 2026, MKS Inc. completed a €1.0 billion private offering of 4.250% senior notes due 2034 placed with institutional investors under Rule 144A and Regulation S, and used the proceeds, together with cash on hand, to prepay approximately $1.3 billion of its existing $2.2 billion U.S. dollar tranche B term loan. On the same date, the company executed a sixth amendment to its credit agreement, refinancing its prior $2.2 billion U.S. dollar tranche B term loan, €587 million euro tranche B term loan and $675 million revolving credit facility into a new $914 million U.S. dollar tranche B term loan, a €587 million euro tranche B term loan and a $1.0 billion revolving credit facility, while extending maturities on the term loan facility to 2033 and the revolver to 2031, lowering margins on both term loans and the revolver, and eliminating the SOFR credit spread adjustment on the revolving facility; collectively, these moves diversify MKS’s capital structure, shift a portion of debt from secured to unsecured, extend its debt maturity profile and reduce interest expense, with the company citing an expected meaningful reduction in annual cash interest costs based on current rates.
The most recent analyst rating on (MKSI) stock is a Buy with a $263.00 price target. To see the full list of analyst forecasts on MKS stock, see the MKSI Stock Forecast page.
On January 26, 2026, MKS Inc. announced plans for a private offering of €1.0 billion in senior unsecured notes due 2034, followed on January 28, 2026, by the announcement of pricing for the issue, which is being placed with qualified institutional buyers under Rule 144A and with non-U.S. investors under Regulation S. The company expects to receive roughly €985 million in net proceeds and, together with proceeds from previously announced refinancings of its $2.2 billion U.S. dollar tranche B term loan and €587 million euro tranche B term loan plus cash on hand, intends to prepay about $1.3 billion of and fully refinance the U.S. dollar tranche B facility and fully refinance the euro tranche B facility, with the note offering scheduled to close on February 4, 2026, subject to customary conditions, in a move that will significantly reshape and extend the company’s debt profile and could reduce its reliance on term-loan financing.
The most recent analyst rating on (MKSI) stock is a Buy with a $260.00 price target. To see the full list of analyst forecasts on MKS stock, see the MKSI Stock Forecast page.
MKS Inc. plans to meet with existing and prospective lenders on January 22, 2026 to discuss a comprehensive refinancing of its capital structure, including replacing its existing $2.2 billion term loan with a new approximately $0.9 billion term loan maturing in 2033, refinancing its existing €0.6 billion term loan with a new facility also maturing in 2033, and enlarging its revolving credit facility from $675 million to $1 billion while extending that facility’s maturity to 2031. The contemplated transactions, which are subject to market conditions and may not close, are designed to be leverage-neutral while extending debt maturities and reducing interest expense, and the company’s accompanying lender presentation emphasizes the use of non-GAAP financial metrics to analyze ongoing business trends and compares past periods, underscoring management’s focus on capital structure optimization amid its exposure to cyclical semiconductor and industrial end markets and risks linked to its Atotech chemicals technology acquisition.
The most recent analyst rating on (MKSI) stock is a Buy with a $227.00 price target. To see the full list of analyst forecasts on MKS stock, see the MKSI Stock Forecast page.